Cointime

Vascugen

company

About

Vascugen is a biotechnology company developing regenerative medicine for treatment of intractable vascular diseases.

  • 11 - 50

Highlights

Total Funding Amount
$835K
Funding Rounds
1
Investors
1

Details

Last Funding Type
Pre-seed
Last Funding Money Raised
$835K
Industries
Biotechnology,Health Care
Founded date
Jan 1, 2017
Number Of Employee
11 - 50
Operating Status
Active

Vascugen is an induced pluripotent stem cell (iPSC) therapy company advancing its novel vasculogenic cell technology to develop and manufacture engineered vascular cells. Our vasculogenic cells have the potential to directly address ischemic disease conditions and to serve as a novel platform for delivery of therapeutic payloads in cardiovascular, solid tumor, and other indications. Vascugen’s research and development facility includes an integrated manufacturing facility for early-stage clinical manufacture of our products.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$835K
Vascugen has raised a total of $835K in funding over 2 rounds. Their latest funding was raised on Nov 16, 2018 from a Pre-seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 16, 2018 Pre-seed $835K 1 Indiana University Philanthropic Venture Fund — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Vascugen is funded by 1 investors. Indiana University Philanthropic Venture Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Indiana University Philanthropic Venture Fund Yes Pre-seed
Cointime
Chủ Đề
Công Ty